Education
About Us
Working with TipRanks
Follow Us
Cooper Co (COO)
NASDAQ:COO
COO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$65.00 - $112.38
Previous CloseN/A
Volume244.93K
Average Volume (3M)2.96M
Market Cap
$13.87B
Enterprise Value$16.33B
Total Cash (Recent Filing)$116.20M
Total Debt (Recent Filing)$2.59B
Price to Earnings (P/E)33.7
Beta0.84
Next Earnings
Aug 27, 2025EPS Estimate
1.07Last Dividend Ex-Date
Jul 26, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)0.96
Shares Outstanding199,512,500
10 Day Avg. Volume2,972,702
30 Day Avg. Volume2,958,380
Financial Highlights & Ratios
PEG Ratio-70.07
Price to Book (P/B)1.68
Price to Sales (P/S)0.00
P/FCF Ratio37.88
Enterprise Value/Market Cap1.18
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit6.46
Enterprise Value/Ebitda3.75
Forecast
1Y Price Target
$95.64Price Target Upside37.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Cooper Co News
Bulls Say, Bears Say
Bulls Say
Earnings And Financial PerformanceThe company reported non-GAAP EPS of $0.96, up 14% year over year, driven by operating leverage following the company’s internal investments.
Product Launch And AdoptionThe broader release of MyDay now that it is no longer supply constrained and MiSight adoption from the longer trials could drive upside to Q4.
Stock ValuationA perceived gap between the company's valuation and its strong fundamentals presents an attractive opportunity for investors.
Bears Say
Market Growth And Consumer TrendsThe overall contacts market growth will be slower due to a softer consumer backdrop.
Product Transition RisksThe company is actively phasing out traditional hydrogel lenses, which might add a degree of risk to short term growth.
Revenue GuidanceCOO lowered FY25 revenue organic growth guidance due to softening in contact lenses and fertility markets.
Ownership Overview
0.23% Insiders
31.90% Mutual Funds
27.50% Other Institutional Investors
14.36% Public Companies and Individual Investors
COO FAQ
What was Cooper Co’s price range in the past 12 months?
Cooper Co lowest stock price was $65.00 and its highest was $112.38 in the past 12 months.
What is Cooper Co’s market cap?
Cooper Co’s market cap is $13.87B.
When is Cooper Co’s upcoming earnings report date?
Cooper Co’s upcoming earnings report date is Aug 27, 2025 which is in 60 days.
How were Cooper Co’s earnings last quarter?
Cooper Co released its earnings results on May 29, 2025. The company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.928 by $0.032.
Is Cooper Co overvalued?
According to Wall Street analysts Cooper Co’s price is currently Undervalued.
Does Cooper Co pay dividends?
Cooper Co pays a Semiannually dividend of $0.007 which represents an annual dividend yield of N/A. See more information on Cooper Co dividends here
What is Cooper Co’s EPS estimate?
Cooper Co’s EPS estimate is 1.07.
How many shares outstanding does Cooper Co have?
Cooper Co has 199,512,500 shares outstanding.
What happened to Cooper Co’s price movement after its last earnings report?
Cooper Co reported an EPS of $0.96 in its last earnings report, beating expectations of $0.928. Following the earnings report the stock price went down -14.607%.
Which hedge fund is a major shareholder of Cooper Co?
Currently, no hedge funds are holding shares in COO
Cooper Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$95.64 (37.24% Upside)
$95.64 (37.24% Upside)
Blogger Sentiment
Bullish
COO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 2.5%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.04%
12-Months-Change
Fundamentals
Return on Equity
5.15%
Trailing 12-Months
Asset Growth
3.04%
Trailing 12-Months
Company Description
Cooper Co
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
COO Company Deck
COO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue and earnings growth, driven by robust performance in key segments like office and surgical, and myopia management. However, challenges such as fertility market softness, reduced market growth assumptions, and tariff impacts were also noted. While the highlights are significant, the lowlights point to underlying market challenges.Read More>COO Net sales Breakdown
66.99% CooperVision
33.01% CooperSurgical
COO Stock 12 Month Forecast
Average Price Target
$95.64
▲(37.24%Upside)